CLVT Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Clarivate PLC (CLVT) is not a strong buy for a beginner, long-term investor at this time. The stock exhibits bearish technical indicators, weak financial performance, and lacks positive catalysts. While hedge funds are increasing their positions, the broader sentiment, including analyst ratings and price target trends, remains cautious. Given the user's preference for long-term investment and the current state of the stock, holding off on investment is recommended until there are clearer signs of improvement.
The technical indicators for CLVT are bearish. The MACD is negatively expanding below 0, the RSI is neutral at 36.821, and the moving averages (SMA_200 > SMA_20 > SMA_5) indicate a downward trend. The stock is trading below the pivot level of 2.508, with key support at 2.393 and resistance at 2.623.
Hedge funds are increasing their positions, with buying up 182.82% over the last quarter.
Analyst ratings and price targets have been consistently downgraded, citing risks such as AI disintermediation, slow revenue growth, and execution risks around asset sales. Financial performance is weak, with significant YoY declines in revenue, net income, EPS, and gross margin. No recent news or congress trading data to suggest a positive shift.
In Q4 2025, revenue dropped by -6.94% YoY to $617M, net income fell by -101.62% YoY to $3.1M, EPS dropped by -100% YoY to 0, and gross margin declined by -3.83% YoY to 36.16%. These figures indicate significant financial struggles.
Analysts have recently lowered price targets, with Citi reducing it to $2.80, RBC Capital to $3, Barclays to $2.40, and Goldman Sachs to $3.10. The ratings reflect concerns about AI competition, slow growth, and execution risks. Stifel remains the only firm with a Buy rating, but it also lowered its target to $6.
